Tecnología en
medicamentos
oncológicos

Calidad, tecnología y sustentabilidad en oncología

Sabemos que la salud es el capital
más preciado de las personas.

Cumpliendo los más altos estándares de calidad internacional, aplicamos innovación y tecnología en la producción de medicamentos inyectables oncológicos.

list of immuno oncology drugs, immuno oncology drugs, care oncology clinic drugs, care oncology drugs, common oncology drugs, drugs used in oncology, immuno oncology drugs list, msd oncology drugs, oncologic drugs advisory committee, oncology drugs, oncology drugs list, oncology drugs market, oncology drugs market size, oncology nursing drug handbook, oncology pipeline drugs, repurposing drugs in oncology, top oncology drugs, top selling oncology drugs, what are oncology drugs, approved immuno oncology drugs, biosimilar oncology drugs, bms immuno oncology drugs, cost of oncology drugs, drug information handbook for oncology, fda approved immuno oncology drugs, fda approved oncology drugs, generic oncology drugs, immuno oncology drug discovery, immuno oncology drugs in development, most expensive oncology drugs, new oncology drugs, oncology chemotherapy drugs, oncology drug classes, oncology drug companies, oncology drug development, oncology drug discovery, oncology drug interactions, oncology drug trails cro oncology drugs advisory committee oncology drugs classification oncology drugs list pdf oncology drugs names

30 años en la industria farmacéutica.

Calidad y tecnología productiva.

Gran capacidad instalada.

Reportes de sustentabilidad bianuales bajo normas GRI y ODS de ONU.

Qué hacemos

En Vivunt Pharma Europe producimos medicamentos oncológicos estériles en viales líquidos y liofilizados. Brindamos el servicio de Contract Development Manufacturing a nivel global.

Reproducir vídeo
Ver más

Donde lo hacemos

Nuestra planta farmacéutica localizada en León, España, cumple con las normas y procedimientos internacionales GMP y los estándares de calidad EMA y FDA.

La tecnología instalada cuenta con la totalidad de los procesos productivos y los controles en proceso (IPC) automatizados. Nuestras instalaciones, maquinarias y procedimientos garantizan el cumplimiento del nuevo Anexo 1 EU GMP’s (2022).

list of immuno oncology drugs, immuno oncology drugs, care oncology clinic drugs, care oncology drugs, common oncology drugs, drugs used in oncology, immuno oncology drugs list, msd oncology drugs, oncologic drugs advisory committee, oncology drugs, oncology drugs list, oncology drugs market, oncology drugs market size, oncology nursing drug handbook, oncology pipeline drugs, repurposing drugs in oncology, top oncology drugs, top selling oncology drugs, what are oncology drugs, approved immuno oncology drugs, biosimilar oncology drugs, bms immuno oncology drugs, cost of oncology drugs, drug information handbook for oncology, fda approved immuno oncology drugs, fda approved oncology drugs, generic oncology drugs, immuno oncology drug discovery, immuno oncology drugs in development, most expensive oncology drugs, new oncology drugs, oncology chemotherapy drugs, oncology drug classes, oncology drug companies, oncology drug development, oncology drug discovery, oncology drug interactions, oncology drug trails cro oncology drugs advisory committee oncology drugs classification oncology drugs list pdf oncology drugs names
list of immuno oncology drugs, immuno oncology drugs, care oncology clinic drugs, care oncology drugs, common oncology drugs, drugs used in oncology, immuno oncology drugs list, msd oncology drugs, oncologic drugs advisory committee, oncology drugs, oncology drugs list, oncology drugs market, oncology drugs market size, oncology nursing drug handbook, oncology pipeline drugs, repurposing drugs in oncology, top oncology drugs, top selling oncology drugs, what are oncology drugs, approved immuno oncology drugs, biosimilar oncology drugs, bms immuno oncology drugs, cost of oncology drugs, drug information handbook for oncology, fda approved immuno oncology drugs, fda approved oncology drugs, generic oncology drugs, immuno oncology drug discovery, immuno oncology drugs in development, most expensive oncology drugs, new oncology drugs, oncology chemotherapy drugs, oncology drug classes, oncology drug companies, oncology drug development, oncology drug discovery, oncology drug interactions, oncology drug trails cro oncology drugs advisory committee oncology drugs classification oncology drugs list pdf oncology drugs names
list of immuno oncology drugs, immuno oncology drugs, care oncology clinic drugs, care oncology drugs, common oncology drugs, drugs used in oncology, immuno oncology drugs list, msd oncology drugs, oncologic drugs advisory committee, oncology drugs, oncology drugs list, oncology drugs market, oncology drugs market size, oncology nursing drug handbook, oncology pipeline drugs, repurposing drugs in oncology, top oncology drugs, top selling oncology drugs, what are oncology drugs, approved immuno oncology drugs, biosimilar oncology drugs, bms immuno oncology drugs, cost of oncology drugs, drug information handbook for oncology, fda approved immuno oncology drugs, fda approved oncology drugs, generic oncology drugs, immuno oncology drug discovery, immuno oncology drugs in development, most expensive oncology drugs, new oncology drugs, oncology chemotherapy drugs, oncology drug classes, oncology drug companies, oncology drug development, oncology drug discovery, oncology drug interactions, oncology drug trails cro oncology drugs advisory committee oncology drugs classification oncology drugs list pdf oncology drugs names

Prensa

list of immuno oncology drugs, immuno oncology drugs, care oncology clinic drugs, care oncology drugs, common oncology drugs, drugs used in oncology, immuno oncology drugs list, msd oncology drugs, oncologic drugs advisory committee, oncology drugs, oncology drugs list, oncology drugs market, oncology drugs market size, oncology nursing drug handbook, oncology pipeline drugs, repurposing drugs in oncology, top oncology drugs, top selling oncology drugs, what are oncology drugs, approved immuno oncology drugs, biosimilar oncology drugs, bms immuno oncology drugs, cost of oncology drugs, drug information handbook for oncology, fda approved immuno oncology drugs, fda approved oncology drugs, generic oncology drugs, immuno oncology drug discovery, immuno oncology drugs in development, most expensive oncology drugs, new oncology drugs, oncology chemotherapy drugs, oncology drug classes, oncology drug companies, oncology drug development, oncology drug discovery, oncology drug interactions, oncology drug trails cro oncology drugs advisory committee oncology drugs classification oncology drugs list pdf oncology drugs names
Leer noticia >
list of immuno oncology drugs, immuno oncology drugs, care oncology clinic drugs, care oncology drugs, common oncology drugs, drugs used in oncology, immuno oncology drugs list, msd oncology drugs, oncologic drugs advisory committee, oncology drugs, oncology drugs list, oncology drugs market, oncology drugs market size, oncology nursing drug handbook, oncology pipeline drugs, repurposing drugs in oncology, top oncology drugs, top selling oncology drugs, what are oncology drugs, approved immuno oncology drugs, biosimilar oncology drugs, bms immuno oncology drugs, cost of oncology drugs, drug information handbook for oncology, fda approved immuno oncology drugs, fda approved oncology drugs, generic oncology drugs, immuno oncology drug discovery, immuno oncology drugs in development, most expensive oncology drugs, new oncology drugs, oncology chemotherapy drugs, oncology drug classes, oncology drug companies, oncology drug development, oncology drug discovery, oncology drug interactions, oncology drug trails cro oncology drugs advisory committee oncology drugs classification oncology drugs list pdf oncology drugs names
Leer noticia >
list of immuno oncology drugs, immuno oncology drugs, care oncology clinic drugs, care oncology drugs, common oncology drugs, drugs used in oncology, immuno oncology drugs list, msd oncology drugs, oncologic drugs advisory committee, oncology drugs, oncology drugs list, oncology drugs market, oncology drugs market size, oncology nursing drug handbook, oncology pipeline drugs, repurposing drugs in oncology, top oncology drugs, top selling oncology drugs, what are oncology drugs, approved immuno oncology drugs, biosimilar oncology drugs, bms immuno oncology drugs, cost of oncology drugs, drug information handbook for oncology, fda approved immuno oncology drugs, fda approved oncology drugs, generic oncology drugs, immuno oncology drug discovery, immuno oncology drugs in development, most expensive oncology drugs, new oncology drugs, oncology chemotherapy drugs, oncology drug classes, oncology drug companies, oncology drug development, oncology drug discovery, oncology drug interactions, oncology drug trails cro oncology drugs advisory committee oncology drugs classification oncology drugs list pdf oncology drugs names
Leer noticia >

Una compañía del grupo farmacéutico VIRIXENE 

Complejo Industrial
Polígono Industrial V8
24392 León
España
comunicaciones@vivunt.es

Youtube Linkedin

Proyecto: Plan Estratégico para el desarrollo y elaboración de medicamentos oncológicos estériles (viales líquidos y liofilizados) en nueva planta farmacéutica de Vivunt Pharma en León.

Objetivo: Realizar el desarrollo galénico y analítico de cuatro medicamentos oncológicos estériles y sus lotes de transferencia tecnológica y validación para registro.

Proyecto financiado por el Fondo Europeo de Desarrollo Regional (FEDER) de la Unión Europea y la Junta de Castilla y León, a través del Instituto para la Competitividad Empresarial de Castilla y León (ICE), con el objetivo de potenciar la investigación, el desarrollo tecnológico y la innovación.

©2022 Vivunt Pharma S.L. | Todos los Derechos Reservados | Aviso Legal | Política de Protección de datos| Políticas de Cookies

¿Te gustaría formar parte
de VIVUNT?

Adjunta tu CV


Comunícate con nuestro equipo